Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)
Italy · Delayed Price · Currency is EUR 1.260
0.00 (0.00%)
At close: Apr 24, 2026
BIT:ERFO Revenue
In the year 2025, Laboratorio Farmaceutico Erfo had annual revenue of 10.03M EUR with 66.31% growth. Laboratorio Farmaceutico Erfo had revenue of 5.06M in the half year ending June 30, 2025, with 53.11% growth.
Revenue
10.03M
Revenue Growth
+58.28%
P/S Ratio
1.07
Revenue / Employee
213.46K
Employees
47
Market Cap
10.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.03M | 4.00M | 66.31% |
| Dec 31, 2024 | 6.03M | 100.36K | 1.69% |
| Dec 31, 2023 | 5.93M | 1.21M | 25.70% |
| Dec 31, 2022 | 4.72M | -287.57K | -5.74% |
| Dec 31, 2021 | 5.01M | 972.01K | 24.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Davide Campari-Milano | 3.05B |
| B.F. S.p.A. | 1.60B |
| Intercos | 1.05B |
| Italmobiliare | 778.71M |
| Centrale del Latte d'Italia | 351.50M |
| Enervit | 100.21M |
| Compagnia dei Caraibi | 52.09M |
| Longino & Cardenal | 35.93M |